Cytiva Europe Competitors and Similar CompaniesClear all
Cytiva Europe's competitors and similar companies include Orbital Therapeutics, Repligen, Pharmaron and STA Pharmaceutical.
 Cytiva Europe Cytiva Europe is a provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. |  Orbital Therapeutics Orbital Therapeutics is a biotechnology company that develops ribonucleic acid (RNA) medicine to treat diseases in humans. |  Repligen Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems. |  Pharmaron Pharmaron (康龙化成(北京)新药技术股份有限公司) is a company that provides drug research, development, and manufacturing services for the life sciences industry. |  STA Pharmaceutical STA Pharmaceutical (also known as WuXi STA, 合全药业, 上海合全药业股份有限公司) is a contract development and manufacturing organization (CDMO) serving the life sciences industry. | |
Founding Date | Founding Date 1993 | Founding Date 2022 | Founding Date 1981 | Founding Date 2004 | Founding Date 2000 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Freiburg im Breisgau, DE HQ | Locations Cambridge, US HQ South San Francisco, US | Locations Waltham, US HQ Shanghai, CN Jüri, EE Castanet Tolosan, FR Ravensburg, DE Bengaluru, IN Waterford, IE see more | Locations Shanghai, CN HQ | |
Employees | Employees 4868% increase | Employees 681% increase | Employees 1,78312% decrease | Employees 21,370 | Employees 4261% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 7.7 b | Valuation ($) 6.7 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €1.1b (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $738.3m (FY, 2025) | Revenue (est.) ¥13.9b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €969.4m (FY, 2021) | Cost of goods N/A | Cost of goods $352m (FY, 2025) | Cost of goods ¥9.2b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €140.2m (FY, 2021) | Gross profit N/A | Gross profit $386.2m (FY, 2025) | Gross profit ¥4.8b (FY, 2025) | Gross profit N/A |
Net income | Net income €35.2m (FY, 2021) | Net income N/A | Net income $48.9m (FY, 2025) | Net income ¥1.6b (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 270m | Total funding raised $ 791.5m | Total funding raised $ 909m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Orbital Therapeutics
HQ
Cambridge, US
Employees
68↑ 1% increase
Orbital Therapeutics is a biotechnology company that develops ribonucleic acid (RNA) medicine to treat diseases in humans.
View companyRepligen
HQ
Waltham, US
Employees
1,783↓ 12% decrease
Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems.
View companyPharmaron
HQ
Beijing, CN
Employees
21,370
Pharmaron (康龙化成(北京)新药技术股份有限公司) is a company that provides drug research, development, and manufacturing services for the life sciences industry.
View companySTA Pharmaceutical
HQ
Shanghai, CN
STA Pharmaceutical (also known as WuXi STA, 合全药业, 上海合全药业股份有限公司) is a contract development and manufacturing organization (CDMO) serving the life sciences industry.
View company